Literature DB >> 3046359

Profound, yet reversible, heart failure secondary to 5-fluorouracil.

S Chaudary1, S Y Song, B E Jaski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3046359     DOI： 10.1016/0002-9343(88)90615-8

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  3 in total

1.  5-fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study.

Authors:  J A Casas; P A Saway; I Villarreal; C Nolte; B L Menajovsky; E E Escudero; W D Blackburn; G S Alarcón; C P Subauste
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 2.  Cardiotoxicity of the antiproliferative compound fluorouracil.

Authors:  K Becker; J F Erckenbrecht; D Häussinger; T Frieling
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

3.  Acute Reversible Heart Failure Caused by Coronary Vasoconstriction due to Continuous 5-Fluorouracil Combination Chemotherapy.

Authors:  Cornelia Dechant; Martina Baur; Rudolf Böck; Martin Czejka; Andrea Podczeck-Schweighofer; Christian Dittrich; Günter Christ
Journal:  Case Rep Oncol       Date:  2012-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.